Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

237.45
-1.2830-0.54%
Post-market: 237.580.1269+0.05%19:30 EDT
Volume:11.62K
Turnover:2.76M
Market Cap:474.08M
PE:- -
High:238.35
Open:238.12
Low:236.49
Close:238.74
52wk High:246.55
52wk Low:171.63
Shares:2.00M
Float Shares:2.00M
Volume Ratio:0.98
T/O Rate:0.58%
Dividend:0.95
Dividend Rate:0.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Revolution Medicines Seen Having 'Strong' Rasonque Launch in Pancreatic Cancer, UBS Says

MT Newswires Live
·
Sep 28

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Reuters
·
Sep 28

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Dow Jones
·
Sep 28

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

TradingKey
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Reuters
·
Sep 28

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Reuters
·
Sep 28

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 28

Regeneron (REGN) Receives a Hold from Bernstein

TIPRANKS
·
Sep 26

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

TIPRANKS
·
Sep 26

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26

US FDA Approves Mirum's Drug for Rare Bone Disorder

Reuters
·
Sep 26

Regeneron Steps Into Obesity Drug Race With New Phase 1 Study

TIPRANKS
·
Sep 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

TIPRANKS
·
Sep 25

Vertex Minerals Sets October General Meeting for Shareholders

TIPRANKS
·
Sep 25

Revolution Medicines Director Elizabeth M. Anderson Disposes of $1,949,321.86 in Common Shares

Reuters
·
Sep 25

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Reuters
·
Sep 25

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Regeneron to Report Q3 Results, Host Conference Call and Webcast

Reuters
·
Sep 25